Epidemiology and Clinical Characteristics of Patients with Multiple Myeloma. Results of a Prospective Multicenter Study in Russian Federation

被引:2
|
作者
Solovev, Maxim V. [1 ]
Mendeleeva, Larisa P. [1 ]
Pokrovskaya, Olga S. [1 ]
Gemdzhian, Eduard [2 ]
Volodicheva, Elena [3 ]
Anchukova, Lyudmila V. [4 ]
Menshakova, Svetlana N. [5 ]
Osyunikhina, Svetlana M. [6 ]
Voytsekhovski, Vladimir V. [7 ]
Savchenko, Valeri G. [8 ]
机构
[1] Natl Res Ctr Hematol, Dept High Dose Chemotherapy, Moscow, Russia
[2] Natl Res Ctr Hematol, Biostat, Moscow, Russia
[3] Tula Reg Clin Hosp, Tula, Russia
[4] Reg Clin Hosp, Vologda, Russia
[5] Reg Clin Hosp, Tver, Russia
[6] Reg Clin Hosp, Saransk, Russia
[7] Reg Clin Hosp, Blagoveshchensk, Russia
[8] Natl Res Ctr Hematol, Moscow, Russia
关键词
D O I
10.1182/blood.V126.23.4248.4248
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:3
相关论文
共 50 条
  • [1] CLINICAL CHARACTERISTICS OF PATIENTS WITH MULTIPLE MYELOMA PRELIMINARY RESULTS OF A PROSPECTIVE MULTICENTER REGISTRY OF THE COMUNIDAD VALENCIANA (SPAIN)
    Cejalvo, M. J.
    Panero, M.
    Ribas, P.
    Jarque, I.
    Lopez, A.
    Perez, P.
    Avaria, A.
    Castillo, I.
    Guinot, M.
    Beltran, S.
    Gascon, A.
    Montava, A.
    Teruel, A.
    Arnao, M.
    Lorente, P.
    Ruiz, M. A.
    Ibanez, F.
    Villarrubia, B.
    Sanchez, J. L.
    Ferrer, R.
    Fernandez, P.
    Blanes, M.
    Mauricio, A.
    Conesa, V.
    de la Rubia, J.
    HAEMATOLOGICA, 2016, 101 : 785 - 786
  • [2] EPIDEMIOLOGIC AND CLINICAL CHARACTERISTICS OF MULTIPLE MYELOMA IN FIVE REGIONS OF RUSSIAN FEDERATION
    Mendeleeva, L.
    Soloviev, M.
    Pokrovskaya, O.
    Volodicheva, E.
    Anchukova, L.
    Men'shakova, S.
    Osunihina, S.
    Voitsehovskiy, V.
    Savchenko, V.
    HAEMATOLOGICA, 2015, 100 : 743 - 743
  • [3] Clinical characteristics of young (age ≤50) patients with multiple myeloma.
    Niesvizky, R
    Lyons, L
    Michaeli, J
    BLOOD, 2000, 96 (11) : 279B - 279B
  • [4] Infection in multiple myeloma: Preliminary results of a multicenter prospective study
    Nucci, M.
    Garnica, M.
    Maiolino, A.
    de Souza, I. R. G.
    Bittencourt, R.
    Silla, L.
    Trabasso, P.
    de Souza, C. A.
    Hungria, V. T.
    Rabagliata, R.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 213 - 213
  • [5] Epidemiology and Clinical Characteristics of Patients with Multiple Myeloma in the United Kingdom
    Raluy, Mireia
    Ramagopalan, Sreeram
    Panjabi, Sumeet
    Lambrelli, Dimitra
    BLOOD, 2014, 124 (21)
  • [6] The complement system in multiple myeloma. A prospective study.
    Lugassy, G
    Platok, I
    Schlesinger, M
    BLOOD, 1997, 90 (10) : 4102 - 4102
  • [7] Rwd Study for Epidemiology and Characteristics of Patients with Multiple Myeloma in Italy
    Corrao, Giovanni
    Montefusco, Vittorio
    De Solda, Francesco
    Finsinger, Paola
    Lanati, Elena
    Orlando, Vito Luigi
    Iorio, Arianna
    Scotti, Lorenza
    BLOOD, 2016, 128 (22)
  • [8] A prospective study of bortezomib in combination with melphalan and prednisone for patients with previously untreated multiple myeloma.
    Gasparetto, C
    Keogh, GP
    Gockerman, JP
    Horwitz, M
    Moore, JO
    DeCastro, C
    Diehl, L
    Davis, P
    Chao, N
    Rizzieri, DA
    BLOOD, 2005, 106 (11) : 379B - 379B
  • [9] Clinical efficacy of pneumococcal vaccination in multiple myeloma patients on novel agents: Results of a prospective clinical study
    Stoma, Igor
    Karpov, Igor
    Iskrov, Igor
    Lendina, Irina
    Uss, Anatoly
    VACCINE, 2020, 38 (30) : 4713 - 4716
  • [10] Epidemiology and Risk Factors for the Development of Infectious Complications in Patients with Multiple Myeloma: A Multicenter Prospective Cohort Study in Latin America
    Riva, Eloisa
    Bove, Virginia
    Vasquez, Jule
    Pena, Camila
    Seehaus, Cristian
    Samanez-Figari, Cesar
    Bustos, Justina
    Hernandez, Marcos
    Fernandez, Julio
    Rios, Rosa Oliday
    Rodriguez, Yusaima
    Figueredo, Irving
    Fantl, Dorotea
    BLOOD, 2021, 138 : 3768 - +